Abstract
Carotid artery stenting (CAS), which has emerged as an alternative therapy to high-risk surgical patients, has become an increasingly important procedure in the optimal management of patients with carotid disease. Current evidence both in symptomatic and in asymptomatic patients suggests that CAS should be performed by skilled operators with formal training and in high-volume centers with a standardized and tailored approach.
A proper tailored approach is based on a profound knowledge of available devices and has been emphasized as the key to achieving a safe practice. Emerging technologies and further innovations pursuing stroke prevention are having wider application and their clinical impact is starting to be evaluated. However, technology advancements must be considered as adjunctive tools in a careful procedural strategy possibly including preprocedural evaluation of CAS technical risks, use of cerebral protection devices, stent selection, and proper management of CAS complications. Following this approach, CAS is intended to be at least as safe and effective as surgical endarterectomy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Robertson JT. Carotid endarterectomy: a Saga of clinical science, personalities, and evolving technology. Willis Lect Stroke. 1998;29:2435–41.
Roubin GS, Iyer S, Halkin A, Vitek J, Brennan C. Realizing the potential of carotid artery stenting proposed paradigms for patient selection and procedural technique. Circulation. 2006;113:2021–30.
Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med. 2000;342:145–53.
Collins R, Armitage J, Parish S, et al.; Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk condi-tions. Lancet. 2004;363:757–67.
Halliday A, Mansfield A, Marro J, et al.; MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: ran-domised controlled trial. Lancet. 2004;363:1491–502.
Yadav JS, Wholey MH, Kuntz RE, et al.; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterecto-my Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–501.
Mas JL, Chatellier G, Beyssen B, et al.; EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355:1660–71.
Mas JL, Trinquart L, Leys D, et al.; EVA-3S Investigators. Endarterectomy versus angioplasty in patients with symptomatic severe carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008;7:885–92.
Ringleb PA, Allenberg J, Brückmann H, et al.; SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006;368:1239–47.
Ederle J, Dobson J, Featherstone RL, et al.; International Carotid Stenting Study investigators. Carotid artery stenting com-pared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375:985–97.
Brott TG, Hobson RW 2nd, Howard G, et al.; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11–23.
Reiff T, Eckstein HH, Amiri H, et al.; SPACE-2 Study Group. Modification of SPACE-2 study design. Int J Stroke. 2014;9:E12–3.
Halliday A, Bulbulia R, Gray W, et al.; ACST-2 Collaborative Group. Status update and interim results from the asymptomat-ic carotid surgery trial-2 (ACST-2). Eur J Vasc Endovasc Surg. 2013;46:510–8.
Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Metzger DC, Wechsler L, Jaff MR, Gray W, ACT I Investigators. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med. 2016;374:1011–20.
Nedeltchev K, Pattynama PM, Biaminoo G, et al.; DEFINE Group. Standardized definitions and clinical endpoints in carotid artery and supra-aortic trunk revascularization trials. Catheter Cardiovasc Interv. 2010;76:333–44.
Krapf H, Nägele T, Kastrup A, et al. Risk factors for periprocedural complications in carotid artery stenting without filter protection: a serial diffusion-weighted MRI study. J Neurol. 2006;253:364–71.
Aronow HD, Shishehbor M, Davis DA, et al. Leukocyte count predicts microembolic Doppler signals during carotid stenting: a link between inflammation and embolization. Stroke. 2005;36:1910–4.
Verhoeven BA, de Vries JP, Pasterkamp G, et al. Carotid atherosclerotic plaque characteristics are associated with micro-embolization during carotid endarterectomy and procedural outcome. Stroke. 2005;36:1735–40.
Biasi GM, Froio A, Diethrich EB, et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the imaging in carotid angioplasty and risk of stroke (ICAROS) study. Circulation. 2004;110:756–62.
de Campos Martins EC, Cremonesi A, Castriota F. Proposed practical anatomical-procedural classification systems for evaluating carotid lesions and carotid artery stenting. EuroIntervention. 2012;8:607–16.
Cremonesi A, Roffi M, Carvalho de Campos Martins E, et al. Carotid Artery Stenting (chapter 42). In: Serruys PW, Wijns W, Vahanian A, editors. Percutaneous interventional cardiovascular medicine. The PCR-EAPCI textbook. Toulouse: PCR Publishing; 2012.
Angelini A, Reimers B, Della Barbera M, et al. Cerebral protection during carotid artery stenting: collection and histopatho-logic analysis of embolized debris. Stroke. 2002;33:456–61.
Crawley F, Clifton A, Buckenham T, et al. Comparison of hemodynamic cerebral ischemia and microembolic signals detected during carotid endarterectomy and carotid angioplasty. Stroke. 1997;28:2460–4.
Al-Mubarak N, Roubin GS, Vitek JJ, et al. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation. 2001;104:1999–2002.
Kastrup A, Gröschel K, Krapf H, et al. Early outcome of carotid angioplasty and stenting with and without cerebral protec-tion devices: a systematic review of the literature. Stroke. 2003;34:813–9.
Reimers B, Schlüter M, Castriota F, et al. Routine use of cerebral protection during carotid artery stenting: results of a multicenter registry of 753 patients. Am J Med. 2004;116:217–22.
Sprouse LR 2nd, Peeters P, Bosiers M. The capture of visible debris by distal cerebral protection filters during carotid artery stenting: is it predictable? J Vasc Surg. 2005;41:950–5.
Cremonesi A, Setacci C, Manetti R, et al. Carotid angioplasty and stenting: lesion related treatment strategies. EuroIntervention. 2005;1:289–95.
Zahn R, Mark B, Niedermaier N, et al. Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Embolic protection devices for carotid artery stenting: better results than stenting without protection? Eur Heart J. 2004;25:1550–8.
Castriota F, Cremonesi A, Manetti R, et al. Impact of cerebral protection devices on early outcome of carotid stenting. J Endovasc Ther. 2002;9:786–92.
Mas JL, Chatellier G, Beyssen B, EVA-3S Investigators. Carotid angioplasty and stenting with and without cerebral protec-tion: clinical alert from the Endarterectomy versus angioplasty in patients with symptomatic severe carotid Stenosis (EVA-3S) trial. Stroke. 2004;35:e18–20.
Wholey MH, Al-Mubarek N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv. 2003;60:259–66.
Whitlow PL, Lylyk P, Londero H, et al. Carotid artery stenting protected with an emboli containment system. Stroke. 2002;33:1308–14.
Rabe K, Sugita J, Gödel H, et al. Flow-reversal device for cerebral protection during carotid artery stenting--acute and long-term results. J Interv Cardiol. 2006;19:55–62.
Bersin RM, Stabile E, Ansel GM, et al. A meta-analysis of proximal occlusion device outcomes in carotid artery stenting. Catheter Cardiovasc Interv. 2012;80:1072–8.
Diederich KW, Scheinert D, Schmidt A, et al. First clinical experiences with an endovascular clamping system for neuro-protection during carotid stenting. Eur J Vasc Endovasc Surg. 2004;28:629–33.
Coppi G, Moratto R, Silingardi R, et al. PRIAMUS – proximal flow blockage cerebral protectIon during carotid stenting: results from a multicenter Italian registry. J Cardiovasc Surg. 2005;46:219–27.
Pinter L, Ribo M, Loh C, et al. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF study. J Vasc Surg. 2011;54:1317–23.
Reimers B, Corvaja N, Moshiri S, et al. Cerebral protection with filter devices during carotid artery stenting. Circulation. 2001;104:12–5.
Nerla R, Castriota F, Micari A, Sbarzaglia P, Secco GG, Ruffino MA, de Donato G, Setacci C, Cremonesi A. Carotid artery stenting with a new-generation double-mesh stent in three high-volume Italian centres: clinical results of a multidisciplinary approach. EuroIntervention. 2016;12:e677–83.
Bosiers M, Deloose K, Torsello G, Scheinert D, Maene L, Peeters P, Müller-Hülsbeck S, Sievert H, Langhoff R, Bosiers M, Setacci C. The CLEAR-ROAD study: evaluation of a new dual layer micromesh stent system for the carotid artery. EuroIntervention. 2016;12:e671–6.
Musialek P, Mazurek A, Trystula M, Borratynska A, Lesniak-Sobelga A, Urbanczyk M, Banys RP, Brzychczy A, Zajdel W, Partyka L, Zmudka K, Podolec P. Novel PARADIGM in carotid revascularisation: prospective evaluation of all-comer peRcutaneous cArotiD revascularisation in symptomatic and increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent system. EuroIntervention. 2016;12:e658–70.
Schofer J, Musiałek P, Bijuklic K, et al. A prospective, multicenter study of a novel mesh-covered carotid stent: the CGuard CARENET trial (carotid embolic protection using MicroNet). JACC Cardiovasc Interv. 2015;8:1229–34.
Bosiers M, de Donato G, Deloose K, et al. Does free cell area influence the outcome in carotid artery stenting? Eur J Vasc Endovasc Surg. 2007;33:135–41.
Castriota F, de Campos Martins EC, Setacci C, et al. Cutting balloon angioplasty in percutaneous carotid interventions. J Endovasc Ther. 2008;15:655–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Nerla, R., Ganesan, K., Micari, A., Castriota, F., Cremonesi, A. (2018). Recent Advances in Carotid Artery Stenting. In: Lanzer, P. (eds) Textbook of Catheter-Based Cardiovascular Interventions. Springer, Cham. https://doi.org/10.1007/978-3-319-55994-0_74
Download citation
DOI: https://doi.org/10.1007/978-3-319-55994-0_74
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55993-3
Online ISBN: 978-3-319-55994-0
eBook Packages: MedicineMedicine (R0)